We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.95%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$193B
AUM Growth
+$9.98B
Cap. Flow
+$5.76B
Cap. Flow %
2.98%
Top 10 Hldgs %
13.3%
Holding
8,497
New
756
Increased
3,610
Reduced
2,944
Closed
742

Sector Composition

Rank Sector Weight
1 Financials 7.75%
2 Healthcare 6.75%
3 Technology 6.26%
4 Industrials 5.06%
5 Consumer Discretionary 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCRO
6751
DELISTED
IQ Hedge Macro Tracker
MCRO
$10K ﹤0.01%
369
CELP
6752
DELISTED
Cypress Environmental Partners, L.P.
CELP
$10K ﹤0.01%
+1,297
New +$10.2K
SORL
6753
DELISTED
SORL Auto Parts, Inc.
SORL
$10K ﹤0.01%
1,540
-3,075
-67% -$18.3K
KONE
6754
DELISTED
Kingtone Wirelessinfo Solution Holding Ltd
KONE
$10K ﹤0.01%
2,594
-15,032
-85% -$54.5K
BZF
6755
DELISTED
WisdomTree Brazilian Real Strategy Fund
BZF
$10K ﹤0.01%
564
-288
-34% -$5.21K
LBTYB
6756
DELISTED
Liberty Global plc Class B
LBTYB
$10K ﹤0.01%
309
+2
+0.7% +$65
ADAP
6757
DELISTED
Adaptimmune Therapeutics
ADAP
$9K ﹤0.01%
2,000
+1,228
+159% +$6.42K
ANIX icon
6758
Anixa Biosciences
ANIX
$117M
$9K ﹤0.01%
7,427
+4,112
+124% +$5.7K
BCLI
6759
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$9K ﹤0.01%
148
-240
-62% -$14.8K
BKTI icon
6760
BK Technologies
BKTI
$301M
$9K ﹤0.01%
+496
New +$11.4K
BYFC icon
6761
Broadway Financial
BYFC
$93.8M
$9K ﹤0.01%
524
-24
-4% -$367
CMPR icon
6762
PUT
Cimpress
CMPR
$2.34B
$9K ﹤0.01%
+100
New +$8.83K
CNOB icon
6763
Center Bancorp
CNOB
$1.65B
$9K ﹤0.01%
+380
New +$8.67K
CNTY icon
6764
Century Casinos
CNTY
$34M
$9K ﹤0.01%
1,231
+382
+45% +$3K
CRD.B icon
6765
Crawford & Co Class B
CRD.B
$485M
$9K ﹤0.01%
937
+549
+141% +$5.33K
CXSE icon
6766
WisdomTree Trust WisdomTree China ex-State-Owned Enterprises Fund
CXSE
$491M
$9K ﹤0.01%
284
-1,196
-81% -$37.6K
DGICB
6767
Donegal Group Class B
DGICB
$9K ﹤0.01%
+649
New +$9.98K
ESQ icon
6768
Esquire Financial Holdings
ESQ
$1.13B
$9K ﹤0.01%
+586
New +$8.83K
FTEC icon
6769
PUT
Fidelity MSCI Information Technology Index ETF
FTEC
$19.8B
$9K ﹤0.01%
+200
New +$8.55K
GTE icon
6770
Gran Tierra Energy
GTE
$258M
$9K ﹤0.01%
401
-855
-68% -$20.8K
HBIO icon
6771
Harvard Bioscience
HBIO
$27.1M
$9K ﹤0.01%
367
-54
-13% -$1.34K
LMB icon
6772
Limbach Holdings
LMB
$866M
$9K ﹤0.01%
+771
New +$9.8K
LTBR icon
6773
Lightbridge
LTBR
$281M
$9K ﹤0.01%
420
+393
+1,456% +$7.53K
MGNX icon
6774
MacroGenics
MGNX
$237M
$9K ﹤0.01%
500
-1,208
-71% -$23K
PFSI icon
6775
PennyMac Financial
PFSI
$3.88B
$9K ﹤0.01%
561
-124
-18% -$2.05K

Similar funds

UBS Group's Q2 2017 Portfolio in Review

As of Q2 2017, UBS Group held 8,497 positions worth $193B, up 5.4% from $183B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2017 filing shows 756 new, 3,610 increased, 2,944 reduced and 742 closed positions. Its largest new stake was Ultra Petroleum Corp. Common Stock: 3,128,785 shares worth $33.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.06B.

By sector, the portfolio is most concentrated in Financials at 7.7% of assets, up from 7.4% a quarter earlier, followed by Healthcare and Technology.

  • UBS Group's largest Q2 2017 buy was Ultra Petroleum Corp. Common Stock: 3,128,785 shares worth $33.9M.
  • UBS Group added most to Monsanto Co in Q2 2017, an estimated $622M increase.
  • UBS Group's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.06B.
  • UBS Group fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $383M.
  • UBS Group's ten largest holdings make up 13% of its $193B portfolio in Q2 2017.
  • UBS Group opened 756 new positions and closed 742 in Q2 2017.
  • UBS Group's portfolio value rose 5.4% quarter-over-quarter to $193B.

Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.